Glucosamine and warfarin alert
Glucosamine is widely used for the symptoms of osteoarthritis. Recent reports have suggested that it may interact with warfarin and thus make blood less likely to clot. The mechanism for this is uncertain. However, Arthritis Australia recommends that patients on warfarin who are starting or stopping glucosamine should have their INR (blood clotting) checked regularly for the first month. Patients who are on stable doses of both are unlikely to have problems.
Prof. Graeme Jones
Arthritis Australia Medical Director
UPDATED: Advice regarding Coronavirus (Covid-19) from the Australian Rheumatology Association
Due to the increasing number of infections in Australia from Coronavirus (Covid-19), we are aware of growing concerns raised by patients with chronic illnesses and...
Reducing opioid harm through regulatory changes – Information for consumers, patients and carers
The Australian Government, through the Therapeutic Goods Administration (TGA) within the Department of Health, is implementing a number of regulatory changes in order to minimise...
PIDA Accessible Packaging Design Special Award 2019
Ecolean received the GOLD award for the Accessible Packaging Design Special Award 2020. Congratulations to Ecolean for their innovative flexible pouch, and to Bannister Downs...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: